Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Correlation Between Tumor-infiltrating Lymphocytes and Response to Systemic Therapy in Breast Cancer

NCT07404462 is registered in ClinicalTrials.gov with Institute of Oncology Ljubljana as lead sponsor.

NCT NCT07404462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07404462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Correlation Between Tumor-infiltrating Lymphocytes and Response to Systemic Therapy in Breast Cancer
Lead sponsor
Institute of Oncology Ljubljana
Phase
Observational
Overall status
Completed
Start date
March 1, 2017
Completion date
March 1, 2022
Enrollment
171 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, early breast cancer